Allergic Disease Onset Prevention Study

NCT05003804 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

283

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Type 1 Hypersensitivity

Interventions

BIOLOGICAL: STMC-103H
BIOLOGICAL: Placebo

Sponsor

Siolta Therapeutics, Inc.